baber/WOPTO huggingface dataset:
Patent MY-179630-A (MY)
Title: Recombinant vector for the treatment of tumor cells
Inventor: ZEENATHUL NAZARIAH BT ALLAUDIN
Filed: 2010-04-02
Abstract: The present invention relates to gene therapy for the treatment of tumors. Accordingly, the present invention discloses recombinant vector expression constructs (vectors) which confer infectivity, replication, transcription, or any combination thereof when the construct is introduced into cells either in vitro or in vivo, with or without a viral particle. The recombinant vector construct is engineered to express a combination of two heterologous nucleotide sequence(s), especially genes encoding an infectious bursal disease polypeptide (VP2) combined with another nucleic acid molecule encoding a chicken anemia virus polypeptide (VP3) or murine endostatin.  Figure 1
Patent MY-173386-A (MY)
Title: A cell-based composition and use thereof for treatment of vernal keratoconjunctivitis
Inventor: Bernard Chin Sze-Piaw
IPC: A61K9/00
Filed: 2016-06-09
Abstract: The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid wherein the cell-based composition is used in a form of medicament for treatment of vernal keratoconjunctivitis.
Patent MY-181252-A (MY)
Title: Tooth and adaptor for attachment of the tooth to a working machine
Inventor: FRANCISCO PEREZ SORIA
Filed: 2014-04-29
Abstract: The present disclosure relates to a tooth (1) for attachment to the lip of a bucket of a working machine, such as an excavator or loader, via an adaptor, the tooth (1) comprising a cavity (103) for receiving a portion of said adaptor, the cavity (103) extending between said first and second opposed outer working surfaces (12, 14) from an open end (104), at said attachment end of the tooth, to a bottom end (105); the cavity (103) being delimited by an inner wall (102); said inner wall (102) comprising first and second internally facing inner walls (106, 107), being the internal surfaces associated with said first outer working surface and said second working outer surface (12,14), respectively, and opposing side walls (108), interconnecting said first and second inner walls (106, 107), the cavity defining a back portion (BP) extending along the Y axis, the back portion being at least partially located between the plane spanned by the X and Z axes and the open end (104) of the cavity, a front portion (FP) extending along the Y axis, the front portion being located between the plane spanned by the X and Z axes and the bottom end (105) of the cavity; and a stepped portion (SP), interconnecting the back portion and the front portion;in the back portion, the first and second inner walls (106, 107), each comprises a pair of essentially planar back contact surfaces (130a, b; 140a,b), being separated by a back divider region (132, 142), extending beyond the pair of first contact surfaces.  The disclosure also relates to an adaptor, and to the coupling between a tooth and an adaptor.  Fig. 1
Patent MY-190024-A (MY)
Title: High melting point chicken fat
Inventor: PERDANA JIMMY
IPC: A23D9/05
Filed: 2017-10-20
Abstract: The invention relates to a high melting point chicken fat produced by dry fractionation of semi-liquid chicken fat. In particularly the invention relates to a chicken fat wherein the chicken fat having a total saturated fat content of 48 to 72 wt% (based on weight of total fat) comprising the fatty acids C16:0 in the range of 36 to 55 wt% (based on weight of total fat) and C18:0 in the range of 11 to 19 wt% (based on weight of total fat).
Patent MY-193535-A (MY)
Title: Cell culture methods
Inventor: YATES ANDREW JEFFREY
IPC: C07K16/00
Filed: 2018-05-29
Abstract: The present invention relates to the use of limited amounts of cysteine and tryptophan in the cell culture medium during production of recombinant proteins, and in particular antibodies. Proteins and antibodies produced under such controlled conditions exhibit reduced heterogeneity, in particular reduced charge variants heterogeneity.
Patent MY-192019-A (MY)
Title: Improved trackless gate
Inventor: WAN SIEW WING
IPC: E06B11/02
Filed: 2018-06-27
Abstract: A trackless gate (10) comprises a pair of first gate panel (8) and a pair of second gate panels (9), at least one gate hanger (1, 2) for mounting the first gate panel (8) onto a gate post and/or wall, at least one gate panel hinge (3, 4) for connecting and pivoting the first gate panel (8) and second gate panel (9), a gate stopper (6) for positioning the trackless gate (10), and a gate bar (5) positioned onto the first gate panel (8) and second gate panel (9) for guiding the gate towards or away from the gate stopper (6).
Patent SG-10201402094Q-A (SG)
Title: A method of reducing downtime of production controls during upgrades
Inventor: ADDALA RAVI
Filed: 2014-05-06
Abstract: 10 : An apparatus for updating the software in a subsea electronics module (SEM), comprises: a first data transmitting and receiving means (1), a second data transmitting and receiving 5 means (2), and a transmission line (3) between the first and the second data transmitting and receiving means (1, 2), wherein packets of data (6) from the first data transmitting and receiving means (1) are transmitted to the second data transmitting and receiving means (2) and aggregated to form a local master, from which software in SEMs may be updated locally. The packets of data (6) may be transmitted using unutilised capacity (5) of the 10 transmission line (3) not required during normal operations. (Fig.2)
Patent SG-10201805428X-A (SG)
Title: Three-dimensional semiconductor devices including vertical structures with varied spacing and methods of forming the same
Inventor: SUNGJOONG KIM
IPC: H01L27/115
Filed: 2018-06-25
Abstract: A three-dimensional semiconductor device is disclosed. The device may include an electrode structure that can include a plurality of electrodes that are stacked on a substrate and extend in a first direction. Vertical structures can penetrate the electrode structure to provide a plurality of columns spaced apart from each other in a second direction crossing the first direction. The plurality of columns can include first and second edge columns located adjacent to respective opposite edges of the electrode structure, and the plurality of columns can include a center column located between the first and second edge columns. Distances between adjacent ones of the plurality of columns can decrease in a direction from the first and second edge columns toward the center column. FIG. 26
Patent SG-10201902706V-A (SG)
Title: Antibodies specific for tgf-beta
Inventor: BEDINGER DANIEL
Filed: 2012-06-01
Abstract: ANTIBODIES SPECIFIC FOR TGF-BETA The present disclosure relates, in general, to materials and methods for antibodies specific for transforming growth factor beta (TGFPβ), including TGFβ1, TGFβ2 and TGFβ3, and uses of these antibodies in the treatment of subjects having cancer, an eye disease, condition or disorder, fibrosis, including ophthalmic fibrosis or fibrosis of the eye, and other conditions or disorders related to T GFβ expression. (NO SUITABLE FIGURE)
Patent SG-10201903641T-A (SG)
Title: Method of bonding a first substrate and a second substrate
Inventor: XIE LING
Filed: 2015-10-23
Abstract: Title of Invention: Method of Bonding a First Substrate and a Second Substrate A method for bonding a first substrate and a second substrate, the first substrate having at least one first connection extending from one side of the first substrate, the method comprising fabricating a first adhesive material around and along a height of the at least one first connection; and bonding the at least one first connection, the first adhesive material, and the second substrate. [FIG. A] 29
Patent SG-10201908921W-A (SG)
Title: Biological and chemical process utilizing chemoautotrophic microorganisms for the chemosythetic fixation of carbon dioxide and/or other inorganic carbon sources into organic compounds, and the generation of additional useful products
Inventor: REED JOHN
Filed: 2010-05-12
Abstract: BIOLOGICAL AND CHEMICAL PROCESS UTILIZING CHEMOAUTOTROPHIC MICROORGANISMS FOR THE CHEMOSYTHETIC FIXATION OF CARBON DIOXIDE AND/OR OTHER INORGANIC CARBON SOURCES INTO ORGANIC COMPOUNDS, AND THE GENERATION OF ADDITIONAL USEFUL PRODUCTS The invention described herein presents compositions and methods for a 10 multistep biological and chemical process for the capture and conversion of carbon dioxide and/or other forms of inorganic carbon into organic chemicals including biofuels or other useful industrial, chemical, pharmaceutical, or biomass products. One or more process steps utilizes chemoautotrophic microorganisms to fix inorganic carbon into organic compounds through chemosynthesis. An additional feature 15 described are process steps whereby electron donors used for the chemosynthetic fixation of carbon are generated by chemical or electrochemical means, or are produced from inorganic or waste sources. An additional feature described are process steps for the recovery of useful chemicals produced by the carbon dioxide capture and conversion process, both from chemosynthetic reaction steps, as well as 20 from non-biological reaction steps. FIG.1 53
Patent SG-11201407703Q-A (SG)
Title: Methanethione compounds having antiviral activity
Inventor: HOMMAN MOHAMMED
IPC: A61K31/44
Filed: 2013-05-17
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 21 November 2013 (21.11.2013) WIPOIPCT (10) International Publication Number WO 2013/171334 A1 (51) International Patent Classification: C07D 249/10 (2006.01) A61K31/44 (2006.01) C07D 261/18 (2006.01) A61P 31/16 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: (30) Priority Data: 61/648,700 61/659,516 61/666,286 61/774,991 PCT/EP2013/060266 17 May 2013 (17.05.2013) English English US US us us 18 May 2012 (18.05.2012) 14 June 2012 (14.06.2012) 29 June 2012 (29.06.2012) 8 March 2013 (08.03.2013) (71) Applicant: VIRONOVA AB [SE/SE]; Gavlegatan 22, S- 11330 Stockholm (SE). (72) Inventors: HOMMAN, Mohammed; Serenadvagen 1 A 8tr, S-13153 Nacka (SE). KINGI, Ngarita; Gardstigen 16, S-12552 Alvsjo (SE). BERGMAN, Jan; Lekgrand 5, S- 163 46 Spanga (SE). ENGQVIST, Robert; Engelbergsva- gen 69, S-144 62 Ronninge (SE). (74) Agent: BRANN AB; P.O. Box 12246, S-10226 Stockholm (SE). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3)) (54) Title: METHANETHIONE COMPOUNDS HAVING ANTIVIRAL ACTIVITY (R )n 1 i-H (57) Abstract: A compound of formula (I), The compound is useful as an antiviral agent, in particular for the treatment of influenza. O A method for preparing the compound of formula (I) and a composition comprising the compound of formula (I).
Patent SG-11201809558P-A (SG)
Title: Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same
Inventor: YASUI RYOTA
IPC: G01N33/577
Filed: 2017-05-26
Abstract: ANTIHUMAN HEMOGLOBIN MONOCLONAL ANTIBODY OR ANTIBODY KIT, INSOLUBLE CARRIER PARTICLE TO WHICH ANTI-HUMAN HEMOGLOBIN MONOCLONAL ANTIBODY IS IMMOBILIZED, AND MEASUREMENT REAGENT AND MEASUREMENT METHOD USING SAME The present invention has an object to provide an anti-human hemoglobin monoclonal antibody or an antibody kit for specifically 10 detecting and measuring a hemoglobin-haptoglobin complex in a sample with ease, and an insoluble carrier particle to which the monoclonal antibody is immobilized, and a measurement reagent and a measurement method for specifically detecting and measuring a hemoglobin-haptoglobin complex in a sample using the same. The 15 anti-human hemoglobin monoclonal antibody of the present invention does not react to free hemoglobin or free haptoglobin which is not forming a complex but specifically reacts to a hemoglobin-haptoglobin complex, when the antibody is immobilized to the insoluble carrier particle and used. 20 NIL 36
Patent SG-11201810066U-A (SG)
Title: Floating traverse system
Inventor: SHERBECK TIMOTHY
IPC: E21B19/15
Filed: 2017-04-12
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 16 November 2017 (16.11.2017) WIPO I PCT omit VIII mum 0 01111011°0 0111 mourn° oimIE (10) International Publication Number WO 2017/196484 Al (51) International Patent Classification: E21B 19/15 (2006.01) (21) International Application Number: PCT/US2017/027212 (22) International Filing Date: 12 April 2017 (12.04.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 15/154,924 13 May 2016 (13.05.2016) US (71) Applicant: FORUM US, INC. [US/US]; 920 Memorial City Way, Suite 1000 , Houston, Texas 77024 (US). (72) Inventors: SHERBECK, Timothy; 22235 Fincastle Dri- ve, Katy, Texas 77450 (US). GUERRA, Gerardo; 11245 West Road, Apt. 135A, Houston, Texas 77065 (US). MEUTH, Joshua Brandon; 208 Woodland Avenue, Gid- dings, Texas 78942 (US). (74) Agent: PATTERSON, B. Todd et al.; PATTERSON & SHERIDAN, LLP, 24 Greenway Plaza, Suite 1600, Hous- ton, Texas 77046 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (54) Title: FLOATING TRAVERSE SYSTEM (57) : In one embodiment, a traverse system configured to move a catwalk relative to a beam, is provided. The system includes a body, an upper brake pad coupled to the body and configured to contact a side of a flange of the beam and a lower brake pad coupled to the body and configured to contact an opposing side of the flange, and an actuator coupled to at least one of the brake pads and configured to move the brake pads between a gripping position that grips the flange and an open position that spaces one of the brake pads away from the flange. [Continued on next page] WO 2017/196484 Al MIDEDIMOMOIDEIROIDEMOMOIHMODIFIDEMOVOIMIE TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
Patent SG-11201900675W-A (SG)
Title: Porous polyether sulfone film and production method therefor
Inventor: OHYA SHUSEI
IPC: C08J9/26
Filed: 2017-07-25
Abstract: POROUS POLYETHER SULFONE FILM AND PRODUCTION METHOD THEREFOR Provided are: a porous polyether sulfone film having macrovoids and having excellent 5 dimensional stability; and a production method therefor. Provided is a porous polyether sulfone film having a surface layer (a), a surface layer (b), and a macrovoid layer interposed between the surface layer (a) and the surface layer (b). The macrovoid layer has a partition wall joined to the surface layers (a) and (b) and a plurality of macrovoids surrounded by the partition wall and the surface layers (a) and (b). The surface layer (a) and the surface layer (b) have pores connected to 10 the macrovoids. [FIG. 1]
Patent SG-11201900973P-A (SG)
Title: Transparent skin sample
Inventor: KAJIYA KENTARO
IPC: G01N1/30
Filed: 2017-08-10
Abstract: TRANSPARENT SKIN SAMPLE The present invention address the problem of providing a transparent skin sample by 5 removing epidermis via enzymatic treatment. [FIG. 2]
Patent SG-11201907539T-A (SG)
Title: Novel dosage form
Inventor: SCHEER MATHIAS
IPC: A61K9/16
Filed: 2018-03-08
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 13 September 2018 (13.09.2018) WIP0 I PCT omit IIl °nolo Oil IIIII Oil IOII im Imo oimIE (10) International Publication Number WO 2018/162688 Al (51) International Patent Classification: A61K 9/16 (2006.01) (21) International Application Number: PCT/EP2018/055847 (22) International Filing Date: 08 March 2018 (08.03.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 17160206.3 09 March 2017 (09.03.2017) EP (71) Applicant: DEVELCO PHARMA SCHWEIZ AG [CH/CH]; HohenrainstraBe 12 D, 4133 Pratteln (CH). (72) Inventors: SCHEER, Mathias; Mozartstrasse 9, 79664 Wehr (DE). REY, Helene; 7a rue du 6eme RIC, 68680 Kembs (FR). (74) Agent: CH KILGER ANWALTSPARTNERSCHAFT MBB; FasanenstraBe 29, 10719 Berlin (DE). = (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). — Published: with international search report (Art. 21(3)) 1-1 • (54) Title: NOVEL DOSAGE FORM GC (57) : The present invention relates to a solid oral pharmaceutical dosage form with a novel and well defined order of specific coatings allowing for the very defined and controlled release of at least one pharmaceutical active ingredient (API) and a broad range of ei potential uses. Particularly, the dosage form according to the invention comprises an immediate release active core, a first delayed-re- lease layer comprising an enteric coating, a second sustained release layer comprising a retard polymer, and a third immediate release 1-1 ▪ layer comprising an active pharmaceutical ingredient. The solid oral pharmaceutical dosage form as such is characterized in having a bi-modal release profile of the at least one API with a much less variable second delayed release than known prior art pharmaceutical 1-1 compositions, allowing for the application of different APIs or combinations thereof in for a variety of indications.
Patent AT-391922-B (AT)
Title: Pressure-medium-actuated piston/cylinder arrangement
IPC: F15B15/22
Filed: 1988-02-26
Granted: 1990-12-27
Abstract: A single-acting piston/cylinder arrangement has a cylinder 1, in which a piston 2 is mounted so as to be displaceable between two end positions. The piston 2 is connected to a piston rod 3 projecting from its one end face 11, so that the effective end face 11 acted upon by pressure medium is smaller there than the effective end face 8, acted upon by pressure medium, on the opposite side of the piston. Provided in the piston are connecting lines 28, which are formed by grooves at the piston circumference, run in the axial direction of the piston 2 and connect the two cylinder spaces 9, 12 to one another. Pressure medium is admitted simultaneously to both cylinder spaces 9, 12. The piston velocity is increased by the overflow of the pressure medium from that cylinder space 12 which is defined by the smaller effective end face 8 of the piston 2 to the opposite cylinder space 9. <IMAGE>
Patent AT-398731-B (AT)
Inventor: STUMPF HORST DIPL ING
IPC: B60C11/01
Filed: 1990-04-25
Granted: 1995-01-25
Abstract: The vehicle pneumatic tyre has a tread profile which is divided up by peripheral grooves and transverse grooves into profile elements. On each shoulder a row of blocks (7) is provided. The transverse grooves have at least one cross-sectional constriction within the series of shoulder blocks (7). <IMAGE>
Patent LT-4046-B (LT)
Title: Device for applying liquid to a warp
Inventor: KREMERS ARNOLD
IPC: B65H71/00
Filed: 1996-01-23
Abstract: PCT No. PCT/EP95/01730 Sec. 371 Date Mar. 18, 1996 Sec. 102(e) Date Mar. 18, 1996 PCT Filed May 6, 1995 PCT Pub. No. WO95/32141 PCT Pub. Date Nov. 30, 1995An apparatus for applying a liquid to threads of a yarn sheet. The apparatus comprises multiple thread wetting elements, each of which has at least one thread guide groove for each thread. In the thread guide groove the thread travels with the liquid and each thread guide groove has one associated liquid feed bore or groove for supplying the liquid to the thread guide groove. The liquid feed bore or groove terminates in the thread guide groove. There is a liquid distributor which is implemented as a support to which the thread wetting elements are attached and which supplies liquid feed to each liquid bore or groove. The separation of adjacent thread guide grooves is 2 to 30 mm, and adjacent thread guide grooves are different distances from the liquid distributor such that the thread guide grooves are offset in an alternating manner.
Patent YU-46827-B (YU)
Inventor: AKRED B J
IPC: C09K23/00
Filed: 1983-02-07
Abstract: Pourable, fluid, non sedimenting, laundry detergent composition, comprising water, surfactant, builder, a surfactant desolubilizing electrolyte and, optionally, the usual minor ingredients, consist essentially of : at least one predominantly aqueous liquid phase which is separable into a distinct layer by centrifuging the composition at 800 times normal earth gravity at 25 DEG  C. for 17 hours, and which contains at least part of the electrolyte and less than 75% by weight, preferably less than 10% by weight, of the surfactant, and one or more other phases which together contain at least part of the builder as solid particles dispersed in the composition and at least part of the surfactant, preferably either as a network of solid surfactant hydrate, or as a "G" phase liquid crystal which may be associated with an "L" phase, micellar solution.